Effect of external beam radiation therapy versus transcatheter arterial chemoembolization for non-diffuse hepatocellular carcinoma (≥ 5 cm): a multicenter experience over a ten-year period
Ke Su(Southwest Medical University), Yunwei Han(Breast Cancer Research Foundation), Zhenying Wu(Affiliated Hospital of Southwest Medical University), Hao Chi(Southwest Medical University), Tao Gu(Southwest Medical University), Yi Jiang(Nanjing University of Chinese Medicine), Lianbin Wen(Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital), Ke Xu(First People's Hospital of Chongqing), Zhaoyang Wang(Binzhou Medical University), Han Li(Hebei Medical University), Jiali Chen(Affiliated Hospital of Southwest Medical University), Jianwen Zhang(Affiliated Hospital of Southwest Medical University), Xueting Li, Yaqi Li(Nanchang University), Yanqiong Song(University of Electronic Science and Technology of China), Kun He(Hebei Medical University), Chenjie Wang(Georgia Institute of Technology), Mengxiang Liu(Southwest Medical University), Qulian Guo(Affiliated Hospital of Southwest Medical University), Fei Wang(Zhejiang Chinese Medical University), Lu Guo(Affiliated Hospital of Southwest Medical University)
Cited by 42
Related Papers
FDA Approval Summary: Nivolumab for the Treatment of Metastatic Non-Small Cell Lung Cancer With Progression On or After Platinum-Based Chemotherapy
|The Oncologist|2016|478
Safety, efficacy and tumor mutational burden as a biomarker of overall survival benefit in chemo-refractory gastric cancer treated with toripalimab, a PD-1 antibody in phase Ib/II clinical trial NCT02915432
|Annals of Oncology|2019|475
Efficacy, Safety, and Correlative Biomarkers of Toripalimab in Previously Treated Recurrent or Metastatic Nasopharyngeal Carcinoma: A Phase II Clinical Trial (POLARIS-02)
|Journal of Clinical Oncology|2021|350